Vertex Pharmaceuticals Incorporated
US ˙ NasdaqGS ˙ US92532F1003

SecurityVRTX / Vertex Pharmaceuticals Incorporated
InstitutionFifth Third Wealth Advisors LLC
Latest Disclosed Ownership2,129 shares
Latest Disclosed Value $ 950,684
Fifth Third Wealth Advisors LLC reports 24.21% increase in ownership of VRTX / Vertex Pharmaceuticals Incorporated

On April 17, 2026 - Fifth Third Wealth Advisors LLC filed a 13F-HR form disclosing ownership of 2,129 shares of Vertex Pharmaceuticals Incorporated (US:VRTX) valued at $950,684 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 15, 2026 disclosing 1,714 shares of Vertex Pharmaceuticals Incorporated. This represents a change in shares of 24.21% during the quarter. The current value of the position is $951,301 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-17 2026-03-31 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 2,129 415 24.21 951 22.27 0.0321
2026-01-15 2025-12-31 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 1,714 -86 -4.78 777 10.37 0.0273
2025-10-21 2025-09-30 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 1,800 -26 -1.42 705 -13.30 0.0260
2025-07-25 2025-06-30 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 1,826 -8 -0.44 813 -8.66 0.0341
2025-04-08 2025-03-31 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 1,834 607 49.47 889 79.96 0.0461
2025-01-14 2024-12-31 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 1,227 230 23.07 494 6.70 0.0268
2024-11-07 2024-09-30 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 997 489 96.26 464 94.54 0.0284
2024-07-23 2024-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 508 508 238 0.0181
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.